Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,115 JPY | -1.12% | +2.08% | +20.86% |
2023 | Kakuyasu Group Co., Ltd. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
2021 | COSMOS Pharmaceutical : Topix closes at near one-month high as investors await earnings | RE |
Sales 2024 * | 131B 828M | Sales 2025 * | 142B 894M | Capitalization | 20.03B 126M |
---|---|---|---|---|---|
Net income 2024 * | 1.87B 11.81M | Net income 2025 * | 2.01B 12.71M | EV / Sales 2024 * | 0.2 x |
Net Debt 2024 * | 6.08B 38.39M | Net Debt 2025 * | 4.38B 27.63M | EV / Sales 2025 * | 0.17 x |
P/E ratio 2024 * |
10.7
x | P/E ratio 2025 * |
9.89
x | Employees | 1,592 |
Yield 2024 * |
2.36% | Yield 2025 * |
2.48% | Free-Float | 21.88% |
1 day | -1.12% | ||
1 week | +2.08% | ||
Current month | +3.98% | ||
1 month | +5.01% | ||
3 months | +17.24% | ||
6 months | -4.30% | ||
Current year | +20.86% |
Managers | Title | Age | Since |
---|---|---|---|
Akihiko Tajima
CEO | Chief Executive Officer | 61 | 09-11-30 |
Hiroyuki Maegaki
DFI | Director of Finance/CFO | - | 02-09-30 |
Junichi Sato
CHM | Chairman | 65 | 81-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Takayuki Oshima
BRD | Director/Board Member | 69 | 21-06-24 |
Junichi Sato
CHM | Chairman | 65 | 81-02-28 |
Akihiko Tajima
CEO | Chief Executive Officer | 61 | 09-11-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2,115 | -1.12% | 4,100 |
24-04-25 | 2,139 | -4.25% | 4,900 |
24-04-24 | 2,234 | +3.52% | 19,400 |
24-04-23 | 2,158 | +1.03% | 3,100 |
24-04-22 | 2,136 | +3.09% | 8,900 |
Delayed Quote Japan Exchange, April 26, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.86% | 127M | |
+2.30% | 6.22B | |
-2.41% | 1.03B | |
-1.35% | 367M | |
+0.33% | 210M | |
-30.73% | 152M | |
+16.54% | 110M | |
-9.87% | 67.56M | |
-27.14% | 51.12M |
- Stock Market
- Equities
- 7686 Stock